Peer Review History
| Original SubmissionMarch 27, 2020 |
|---|
|
PONE-D-20-08720 Osteoporosis in HIV-positive Young Italians and Migrants PLOS ONE Dear Prof. Sergi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. As you can find from the comments noted below, the authors should address samples size and provide details of the study like exclusion and inclusion criteria of subjects with a clear hypothesis. The second reviewer also suggested the manuscript should be proof read for English language. We would appreciate receiving your revised manuscript by Jun 06 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Dr. Sakamuri V. Reddy Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 3. Thank you for stating the following in the Acknowledgments Section of your manuscript: 'This study was funded by an intramural grant of the University of Palermo, Italy.' We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: 'The authors received no specific funding for this work.'
Please include your amended statements within your cover letter; we will change the online submission form on your behalf. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: No ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for inviting me to review this manuscript which compares the prevalence of OP in HIV positive italians versus migrants. Overall, the manuscript is well written. Below are a few suggestions that may improve the manuscript. Introduction The paragraph regarding OP, its definition and associated factors is unnecessary. The OP should relate the prevalence of OP to HIV + individuals instead. The authors should also perform a review of whether previous studies have looked into the prevalence of OP in HIV+ pts in Italy prior to this. Methods Sample size is rather small. Was sample size calculation performed? was data normally distributed? If data not normally distributed, continuous variables should be presented as median and IQR (refer table 1). Please state the median and IQR for BMI as well. Non parametric tests should be used for the analyses as well. BMD assessment For younger age pts, it has been recommended that the z-score is used instead of the t-score. Results Table 1 and 2 can be merged. Results can be summarised more succintly. Highlight the importance of the results, rather than repeat what is already presented in the table. Why was logistic regression not performed? It would be interesting to see the OR of a italian or migrant developing OP. Discussion. The first para of the discussion should highlight the most important findings, followed by discussion of the results. A lot of the material (regarding past similar studies done in Italy) in the first para should be moved to introduction. The discussion should also be shortened. It's currently a very long read. Limitations should be added regarding the small sample size Reviewer #2: General Comments:Much better suited (after major revision) for an HIV-specific journal – as there is little to be learned for a general medical audience from this study. Would rewrite this with the help of a native English speaker into a much more descriptive paper – not “hunting” for statistical significance. Specific Comments: (Relatively) small comparative cross-sectional study on bone mineral density in HIV-infected, ART-naïve (mostly African) recent migrants and native Italians from Sicily. The major problems with this study are: - no underlying hypothesis - no clear inclusion/exclusion criteria (who got a DXA scan and why?) what was the exact age range in each group? - the major “finding” was a much higher rate of osteoporosis/osteopenia in migrant women compared with Italian women – that seemed to be explained by low rate of osteopenia in Italian women in their sample and likely also by much more advanced HIV disease in migrant women – but the authors unfortunately did not delineate HIV-specific and other osteoporosis by gender and migrant status. Important questions: menopause status? History of TB? Minor points: see comments in edited .pdf file. - Would elaborate on implications for ART management and longitudinal monitoring in discussion and discuss osteoporosis treatment ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-20-08720R1 Low Bone Mineral Density in HIV-positive Young Italians and Migrants PLOS ONE Dear Dr. Sergi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Specifically: The authors should follow the minor comments/suggestions of the reviewer-2 as noted below proof reading the manuscript for grammatical errors and to further improve. Please submit your revised manuscript by Aug 27 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Dr. Sakamuri V. Reddy Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: General points: You went through great lengths to address most of the reviewers points- thanks! Still, PLEASE find somebody who is proficient in English or use the F7 key in Microsoft Word to correct the many glaring grammatical mistakes in your paper. THANKS! I stick with my opinion that your main finding, the difference in BMD between migrants and native Italians concerns only women and it may or may not have anything to do with HIV. If no data menopause status were available for your study, you should state so in Methods and mention this as a limitation in your Discussion. An alternative explanation would be differences in sun exposure and this could involve cultural factors, depending on the origin/culture/religious habits of the migrant women in your study. Table 2 with the 25-OH Vitamin D values is confusing me, particularly the "abnormal" (<12 ng/mL?) category doesn't seem to make sense - was really everybody abnormal??? Migrant women seem to have much higher levels than men, which is unexpected - the opposite was true for native Italians. PLEASE, look at your source data again and make sure that you are publishing correct numbers.... ITA MIG Abnormal 25-OH-vitD 100% (59/59) 100% (24/24) 1.00 (F) Male 69.5% (41/59) 33% (8/24) 0.0024* (C) Female 31.5% (18/59) 66.7% (16/24) 0.0024* (C) 25-OH-vitD (ng/mL) 14.8±6.4 11.8±5.4 0.0466 * (T) Male 15.6±6.9 9.8±5.9 0.0324 * (T) Female 12.9±4.4 12.8±5.2 0.94 (T) Finally, I like the color-coded z-score Figures that are juxtoposing the ITA and the MIG group. However, I think they ought to be c o m p l e t e l y rearranged - make one figure for femoral and one for lumbar BMD, ITA group left, MIG group right. And then SORT the individual values for each group (maintaining stratification by gender) from lowest to highest. This will make the most meaningful graphical depiction of your findings. For the CD4 / BMD scatterplots, I would keep the scale of the x-axis for both groups identical, i.e. considerably shorten the x-axis for the MIG group. This will make the groups easier to compare. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: Yes: Henning Drechsler [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Low Bone Mineral Density in HIV-positive Young Italians and Migrants PONE-D-20-08720R2 Dear Dr. Sergi, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Dr. Sakamuri V. Reddy Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .